The Latest Breaking News from Novo Nordisk

California's Attorney General Rob Bonta sued the six major companies that dominate the U.S. insulin market

Eli Lilly & Co., Novo Nordisk AS and Sanofi were sued by California over insulin prices, which the state claims are inflated through unfair and deceptive practices and disproportionately affect low-income households and people of color.

Many Americans turn to the latest big idea to lose weight — fad diets, fitness crazes, dodgy herbs and pills, bariatric surgery, just to name a few. They’re rarely the magic solution people dream of.

Concerns emerge over a wave of new startups offering access to drugs called GLP-1 agonists

A diabetes drug is all the rage among Hollywood’s elite, but folks who need the drug are struggling to get it

Insulin producers Eli Lilly, Novo Nordisk and Sanofi all reported losses during Friday’s trading

In Beverly Hills’ doctors offices, celebrities are clamoring for Ozempic prescriptions – but what are the costs of the supposed wonder drug?

Rising prevalence of chronic diseases and the increasing aging population are significant growth drivers of the healthcare industry. Moreover, growing investments in technological advancements should bode well for the industry. Thus, we think investing in quality healthcare stocks Johnson & Johnson (JNJ), Pfizer (PFE), Novo Nordisk (NVO), Bristol-Myers Squibb (BMY),…

Amid an uncertain market, it becomes increasingly difficult for investors to find stocks that can survive the challenges and deliver solid returns. Accel Entertainment (ACEL), Novo Nordisk (NVO), and Titan Machinery (TITN) are currently not on investors’ radar, but it could be worth adding these stocks to one’s portfolio given…